Given the experimental evidence that GAU1/GALNT8 axis overexpression significantly promotes the cancer cell proliferation and GAU1 boosts cell cycle by increasing S-phase entry, we further questioned if GAU1/GALNT8 axis can reshape the drug response of cancer cells to chemotherapy agents targeting DNA replication. Here, GALNT8 is linked to cancer.